Detalhe da pesquisa
1.
Application of natural language processing to predict final recommendation of Brazilian health technology assessment reports.
Int J Technol Assess Health Care
; 40(1): e19, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605654
2.
Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease.
J Bras Nefrol
; 45(3): 365-372, 2023.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-37015047
3.
Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease.
J Bras Nefrol
; 45(1): 95-101, 2023.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-35980102
4.
Clinical effectiveness of screening for age-related macular degeneration: A systematic review.
PLoS One
; 18(11): e0294398, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971992
5.
Exploring the COVID-19 Pandemic's Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System.
Value Health Reg Issues
; 37: 18-22, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196546
6.
Direct cost of systemic arterial hypertension and its complications in the circulatory system from the perspective of the Brazilian public health system in 2019.
PLoS One
; 16(6): e0253063, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111216
7.
Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease / Análise de custo-efetividade do paricalcitol intravenoso vs. calcitriol oral no tratamento do hiperparatireoidismo secundário à doença renal crônica
J. bras. nefrol
; 45(1): 95-101, Jan.-Mar. 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1430642
8.
Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease / Análise de custo-efetividade do cinacalcete vs. paricalcitol no tratamento do hiperparatireoidismo secundário à doença renal crônica
J. bras. nefrol
; 45(3): 365-372, Sept. 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1521091